Cerebrospinal fluid metabolomes of treatment-resistant depression subtypes and ketamine response: a pilot study
Abstract Depression is a disorder with variable presentation. Selecting treatments and dose-finding is, therefore, challenging and time-consuming. In addition, novel antidepressants such as ketamine have sparse optimization evidence. Insights obtained from metabolomics may improve the management of...
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Springer
2024-04-01
|
| Series: | Discover Mental Health |
| Online Access: | https://doi.org/10.1007/s44192-024-00066-5 |